Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 16 to 30 of 352 results for covid-19

  1. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158)

    This guideline covers diagnosing and managing venous thromboembolic diseases in adults. It aims to support rapid diagnosis and effective treatment for people who develop deep vein thrombosis (DVT) or pulmonary embolism (PE). It also covers testing for conditions that can make a DVT or PE more likely, such as thrombophilia (a blood clotting disorder) and cancer.

  2. Maintaining a cancer service in the midst of the COVID-19 pandemic: A single centre experience

    was placed in lockdown to try and counter the rising number of cases of COVID-19. Even before this date, hospitals were preparing for...

  3. Project CARE: Supporting people with a positive diagnosis of COVID-19 and reaching out to those in vulnerable groups

    March 2021 Project CARE COVID-impact Assessment & Response project by a team led by Dr Olukayode Adeeko (Newton

  4. The effect of COVID-19 related lockdown on patients taking warfarin

    a therapeutic range in order to remain safe We looked at the time pre COVID 19 pre lockdown lockdown and post lockdown and noted that...

  5. Cough (acute): antimicrobial prescribing (NG120)

    This guideline sets out an antimicrobial prescribing strategy for acute cough associated with an upper respiratory tract infection or acute bronchitis in adults, young people and children. It aims to limit antibiotic use and reduce antibiotic resistance.

  6. COVID-19 vaccine hesitancy – debunking the myths using a community engagement approach underpinned by NICE guidance

    Women in Health (BWIH) reduced COVID-19 vaccine hesitancy amongst the BAME population by debunking the myths about COVID-19...

  7. Cytokine adsorption devices for treating respiratory failure in people with COVID-19 (MIB217)

    NICE has developed a medtech innovation briefing (MIB) on cytokine adsorption devices for treating respiratory failure in people with COVID-19 .

  8. Supporting and developing community end of life care during the COVID-19 pandemic: an example of collaborative working

    2020 At the onset of the COVID-19 pandemic, as community providers of end of life care services, we anticipated

  9. Impact of COVID-19 on Carers: Caring for Carers - Can we be of help?

    psychological, emotional, financial etc.) of the carers To assess the impact of COVID-19 on their role specifically To offer practical...

  10. COVID-19 ready rehabilitation for heart failure: REACH-HF can deliver

    the hospital) that is easily accessible for the person'. However, in the COVID-19 era, centre-based options are limited and there has...

  11. CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic (MIB219)

    NICE has developed a medtech innovation briefing (MIB) on CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic .

  12. Developing and implementing guidance for staff delegating clinical tasks to informal carers and relatives during the COVID-19 pandemic

    accelerated to deliver appropriate care to patients at the end of life during the COVID-19 pandemic in the UK during Spring 2020. The...

  13. Fenfluramine for treating seizures associated with Lennox–Gastaut syndrome in people 2 years and over [ID1651]

    In development [GID-TA10653] Expected publication date: 22 May 2024

  14. Ensitrelvir for treating COVID-19 [ID6231]

    Awaiting development [GID-TA11224] Expected publication date: TBC

  15. Antenatal care (QS22)

    This quality standard covers the routine antenatal care that women and their babies should receive during pregnancy. It describes high-quality care in priority areas for improvement.